Daily Derm Times: July 8, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Jasper Investigates Drug Lot Issue in CSU Study

Jasper Therapeutics reveals promising results from briquilimab trials for chronic spontaneous urticaria, showcasing strong efficacy and safety despite manufacturing challenges.

New AI Model Aids Early CSCC Risk Stratification

AI enhances early detection of high-risk cutaneous squamous cell carcinoma (CSCC) by integrating advanced histopathological assessments for improved patient outcomes.

ILDS, ISD Commemorate World Skin Health Day 2025 With ‘No Health without Skin Health’ Theme

World Skin Health Day 2025 unites global leaders to advocate for skin health equity, emphasizing the urgent need for accessible dermatological care worldwide.

Data Shows Spesolimab Maintains Skin Clarity Between GPP Flares

Spesolimab effectively targets IL-36 receptor, reducing inflammation and preventing flares in generalized pustular psoriasis, offering new hope for patients.

Q&A With the NEA: Vetting Eczema-Safe Products Through the Seal of Acceptance

The NEA’s Sam Iannotti, MPH, discusses how the Seal of Acceptance helps patients and clinicians identify products that meet rigorous eczema care standards.